Page 77 - Sohini Das

Bharat Serums working on polyclonal antibody product for Covid-19 treatment

The company has invested Rs 100 cr in manufacturing capex in the last one year

How Gennova is developing India's first indigenous mRNA Covid-19 shot

Where Gennova scores is that it has achieved to crack the stringent sub-zero temperature requirements

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

Vaccines for malaria and dengue may hit Indian market in 2-4 years

There are several candidates in the works - the Serum Institute of India, Bharat Biotech, and Zydus Cadila are working on either developing or manufacturing anti-malarial vaccines

Corporate hospitals expect revenue and margins to surpass pre-Covid times

Non-Covid occupancies, higher average revenue per occupied bed, cost rationalisation driving growth

Expert panel allows adolescent trials of J&J vaccine with riders

SEC asks J&J to monitor adverse events closely for next three months

New-age pharmacy start-ups tap 'kirana' networks, eye US market

New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland

Demerger to give a push to both pharma and financial services: Ajay Piramal

In a Q&A, the Chairman of Piramal Group talks about the prospects of both businesses, the rationale for the demerger and how supply side issues are impacting Indian companies

Piramal Enterprises board approves to demerge and list pharma business

The demerger will give potential investors the option of being associated with the business of their choice

Bharat Biotech submits clinical trial data for paediatric vaccine to DCGI

The vaccine maker added that Covaxin is the first Covid-19 vaccine to be tested in the 2-6-year age group

Covid-19 vaccine needs an injection of pace to keep up with syringe demand

The inoculation programme may suffer from a syringe shortage

WHO technical advisory group to take call on Covaxin EUL next week

Vaccine maker presented data before SAGE working group on Tuesday

Syringe makers expect export of items with low demand in India to continue

Industry estimates India has stockpile to last about a month for Covid-19 vaccination

States not on same page as govt gears up to roll out digital health mission

Tamil Nadu plans parallel programme with unique user IDs

Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India

Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the 'Big Three', control over 90 per cent of the global insulin market

Bharat Biotech injects pace into Covid-19 vaccine Covaxin supply

Constraints on the availability of India's first indigenous Covid-19 vaccine could end soon

Bharat Biotech likely to start manufacturing Covaxin at Pune plant soon

Animal vaccine maker Hester Biosciences, on the other hand, is setting up a greenfield BSL-3 facility in Gujarat to make Covaxin

India warns of 'reciprocal measures' if UK doesn't recognise Covishield

India on its part does not insist on vaccination and has done away with institutional quarantine for foreigners entering the country

India to resume export of Covid vaccines from October: Mansukh Mandaviya

Sources say the Centre has been working to create a stockpile of vaccines for India in case a third wave strikes

Mylab picks up majority stake in point-of-care testing firm

Sanskritech has develop a point of care testing platform Swayam that can do 70 tests on the spot